983P Camrelizumab (C) in combination with apatinib (A) in patients with advanced hepatocellular carcinoma (RESCUE): An open-label, multi-center, phase II trial

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1099 ◽

2020 ◽

Vol 31 ◽

pp. S689

Author(s):

J. Xu ◽

J. Shen ◽

S. Gu ◽

Y. Zhang ◽

L. Wu ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Hepatocellular Carcinoma ◽

Download Full-text

Efficacy, Safety and Biomarker Analysis of CD133-Directed CAR T Cells in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3522567 ◽

2020 ◽

Author(s):

Hanren Dai ◽

Chuan Tong ◽

Fan Zhao ◽

Meixia Chen ◽

Yelei Guo ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

T Cells ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Hepatocellular Carcinoma ◽

Car T Cells ◽

Biomarker Analysis ◽

Car T ◽

Open Label Phase

Download Full-text

Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trial

OncoImmunology ◽

10.1080/2162402x.2020.1846926 ◽

2020 ◽

Vol 9 (1) ◽

pp. 1846926

Author(s):

Hanren Dai ◽

Chuan Tong ◽

Daiwei Shi ◽

Meixia Chen ◽

Yelei Guo ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

T Cells ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Hepatocellular Carcinoma ◽

Car T Cells ◽

Biomarker Analysis ◽

Car T ◽

Open Label Phase

Download Full-text

Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial

10.1186/s12885-018-4519-y ◽

2018 ◽

Vol 18 (1) ◽

Author(s):

Masahiro Hatooka ◽

Tomokazu Kawaoka ◽

Hiroshi Aikata ◽

Yuki Inagaki ◽

Kei Morio ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Hepatic Arterial Infusion ◽

Hepatic Arterial Infusion Chemotherapy ◽

Advanced Hepatocellular Carcinoma ◽

Arterial Infusion ◽

Arterial Infusion Chemotherapy ◽

Infusion Chemotherapy

Download Full-text

CD133-Directed CAR T Cells in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3514712 ◽

2020 ◽

Author(s):

Hanren Dai ◽

Chuan Tong ◽

Fan Zhao ◽

Meixia Chen ◽

Yelei Guo ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

T Cells ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Hepatocellular Carcinoma ◽

Car T Cells ◽

Car T ◽

Open Label Phase

Download Full-text

Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-011-1753-2 ◽

2011 ◽

Vol 69 (3) ◽

pp. 773-780 ◽

Author(s):

Iacopo Petrini ◽

Monica Lencioni ◽

Miriam Ricasoli ◽

Mauro Iannopollo ◽

Cinzia Orlandini ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Hepatocellular Carcinoma

Download Full-text

Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma

Journal of Hepatology ◽

10.1016/j.jhep.2011.07.033 ◽

2012 ◽

Vol 56 (2) ◽

pp. 486-487 ◽

Author(s):

Jairo A. Garcia ◽

Lewis R. Roberts

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Advanced Hepatocellular Carcinoma ◽

Open Label Study ◽

Label Study ◽

First Line Therapy ◽

Download Full-text

982P Comparison of donafenib and sorafenib as advanced hepatocellular carcinoma first-line treatments: Subgroup analysis of an open-label, randomized, parallel-controlled, multicentre phase II/III trial

Annals of Oncology ◽

10.1016/j.annonc.2020.08.1098 ◽

2020 ◽

Vol 31 ◽

pp. S688

Author(s):

S. Qin ◽

F. Bi ◽

C. Cui ◽

B. Zhu ◽

J. Wu ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Subgroup Analysis ◽

Advanced Hepatocellular Carcinoma ◽

Multicentre Phase

Download Full-text

Phase II Trial of Hepatic Arterial Infusion Chemotherapy Using Cisplatin and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma

Progress in Hepatocellular Carcinoma Treatment ◽

10.1007/978-4-431-67913-4_7 ◽

2000 ◽

pp. 49-55 ◽

Author(s):

Masatoshi Tanaka ◽

Eiji Ando ◽

Sigeru Yutani ◽

Kazuta Fukumori ◽

Ryoko Kuromatsu ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Phase Ii Trial ◽

Hepatic Arterial Infusion ◽

Hepatic Arterial Infusion Chemotherapy ◽

Advanced Hepatocellular Carcinoma ◽

Arterial Infusion ◽

Arterial Infusion Chemotherapy ◽

Infusion Chemotherapy

Download Full-text

A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepatocellular carcinoma

British Journal of Cancer ◽

10.1038/s41416-018-0051-8 ◽

2018 ◽

Vol 118 (9) ◽

pp. 1162-1168 ◽

Author(s):

D. H. Palmer ◽

Y. T. Ma ◽

M. Peck-Radosavljevic ◽

P. Ross ◽

J. Graham ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase I ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Hepatocellular Carcinoma ◽

Open Label Phase

Download Full-text

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma

10.1186/1471-2407-10-209 ◽

2010 ◽

Vol 10 (1) ◽

Author(s):

Tim F Greten ◽

Alejandro Forner ◽

Firouzeh Korangy ◽

Gisele N'Kontchou ◽

Nathalie Barget ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Phase Ii ◽

Advanced Hepatocellular Carcinoma ◽

Peptide Vaccination ◽

Safety And Efficacy ◽

Open Label Trial

Download Full-text